The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: External validation of the EORTC risk tables

1. Fernandez-Gomez, J.
2. Madero, R.
3. Solsona, E.
4. Unda, M.
5. Martinez-Piñeiro, L.
6. Ojea, A.
7. Portillo, J.
8. Montesinos, M.
9. Gonzalez, M.
10. Pertusa, C.
11. Rodriguez-Molina, J.
12. Camacho, J.E.
13. Rabadan, M.
14. Astobieta, A.
15. Isorna, S.
16. Muntañola, P.
17. Gimeno, A.
18. Blas, M.
19. Martinez-Piñeiro, J.A.